Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Wink A de Boer. (2001) A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule. Expert Opinion on Investigational Drugs 10:8, pages 1559-1566.
Read now
Read now
A. MEINING, W. HÖCHTER, J. WEINGART, A. SOMMER, H. KLANN, T. SIMON, F. HUBER, K.-H. BOLLE, R. HATZ, G. FISCHER, N. LEHN, M. STOLTE, E. BAYERDÖRFFER. (1998) Double-Blind Trial of Omeprazole and Amoxicillin in the Cure of Helicobacter pylori Infection in Gastric Ulcer Patients. Scandinavian Journal of Gastroenterology 33:1, pages 49-54.
Read now
Read now
David I. Grove, George Koutsouridis & Adrian G. Cummins. (1998) Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline. Pathology 30:2, pages 183-187.
Read now
Read now
Robert A Kozol. (1996) Editorial: Anti-infectives: Helicobacter pylori and peptic ulcer disease: Recent developments. Expert Opinion on Investigational Drugs 5:2, pages 145-149.
Read now
Read now
R. W. M. Van Der Hulst & G. N. J. Tytgat. (1996) Helicobacter pylori and Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 31:sup220, pages 10-18.
Read now
Read now
Articles from other publishers (53)
Sun Min Lee. 2016. Helicobacter pylori. Helicobacter pylori
405
413
.
Patrick F. McDermott, Joanne L. Simala-Grant & Diane E. Taylor. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
847
863
.
Xiao-Hui Huo. (2006) Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients. World Journal of Gastroenterology 12:19, pages 3105.
Crossref
Crossref
Wei-Hao Sun. (2005)
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of
Helicobacter pylori
in Chinese peptic ulcer patients
. World Journal of Gastroenterology 11:16, pages 2477.
Crossref
Crossref
Chun‐Jung Lin, Jyh‐Chin Yang, Yow‐Shieng Uang, Herng‐Der Chern & Teh‐Hong Wang. (2012) Time‐Dependent Amplified Pharmacokinetic and Pharmacodynamic Responses of Rabeprazole in Cytochrome P450 2C19 Poor Metabolizers. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23:6, pages 711-719.
Crossref
Crossref
N Kalach, P.H Benhamou, M Bergeret, F Gottrand, M.O Husson, C Barbier, C Dupont & J Raymond. (2002) Acquisition d’une résistance secondaire après échec d’un premier traitement lors de l’infection à Helicobacter pylori chez l’enfant. Archives de Pédiatrie 9:2, pages 130-135.
Crossref
Crossref
Margaret A Jorgensen, Mark A Trend, Stuart L Hazell & George L Mendz. (2001) Potential Involvement of Several Nitroreductases in Metronidazole Resistance in Helicobacter pylori. Archives of Biochemistry and Biophysics 392:2, pages 180-191.
Crossref
Crossref
G. J. B. Hurenkamp, A. Van Der Ende, H. G. L. M. Grundmeijer, G. N. J. Tytgat & R. W. M. Van Der Hulst. (2000)
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate
Helicobacter pylori
infection in patients with ulcer disease
. Alimentary Pharmacology & Therapeutics 14:8, pages 1065-1070.
Crossref
Crossref
Michopoulos, Tsibouris, Bouzakis, Balta, Vougadiotis, Broutet & Kralios. (2001)
Randomized study comparing omeprazole with ranitidine as anti‐secretory agents combined in quadruple second‐line
Helicobacter pylori
eradication regimens
. Alimentary Pharmacology & Therapeutics 14:6, pages 737-744.
Crossref
Crossref
Eng‐Kiong Teo, Kwong‐Ming Fock, Tay Meng Ng, Christopher Jen Lock Khor & Ai Ling Tan. (2001)
Metronidazole‐resistant
Helicobacter pylori
in an urban Asian population
. Journal of Gastroenterology and Hepatology 15:5, pages 494-497.
Crossref
Crossref
Wink A. Boer, Ruud J.X.M. Etten, Peter M. Schneeberger & Guido N.J. Tytgat. (2000) A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule. The American Journal of Gastroenterology 95:3, pages 641-645.
Crossref
Crossref
Lehmann, Drewe, Terracciano & Beglinger. (2001)
Effect of ornidazole and clarithromycin resistance on eradication of
Helicobacter pylori
in peptic ulcer disease
. Alimentary Pharmacology & Therapeutics 14:3, pages 305-309.
Crossref
Crossref
Yvette J. Debets-OssenkoppRaymond G. J. PotDavid J. van WesterlooAvery Goodwin, Christina M. J. E. Vandenbroucke-GraulsDouglas E. Berg, Paul S. Hoffman & Johannes G. Kusters. (1999)
Insertion of Mini-IS
605
and Deletion of Adjacent Sequences in the Nitroreductase (
rdxA
) Gene Cause Metronidazole Resistance in
Helicobacter pylori
NCTC11637
. Antimicrobial Agents and Chemotherapy 43:11, pages 2657-2662.
Crossref
Crossref
Agatha E. Ani, A.O. Malu, J.A. Onah, D.M.M. Queiroz, G. Kirschner & G.A. Rocha. (1999) Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 93:6, pages 659-661.
Crossref
Crossref
Lurdes Monteiro. (1999) Principe du traitement de l'infection par Helicobacter pylori et rôle du biologiste dans sa surveillance. Revue Française des Laboratoires 1999:316, pages 55-62.
Crossref
Crossref
Ahmet Uygun, Yüksel Ates, Ahmet Erdil, Abdurrahman Kadayifci, Celalettin Cetin, Mustafa Gulsen, Necmettin Karaeren & Kemal Dagalp. (1999) Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. Clinical Therapeutics 21:9, pages 1539-1548.
Crossref
Crossref
E J van der Wouden, J C Thijs, A A van Zwet, W J Sluiter & J H Kleibeuker. (1999) The Influence of in Vitro Nitroimidazole Resistance on The Efficacy of Nitroimidazole-Containing Anti- Helicobacter Pylori Regimens: A Meta-Analysis. American Journal of Gastroenterology 94:7, pages 1751-1759.
Crossref
Crossref
Houben, Hensen, Rauws, R. W. M. Van Der Hulst, B. W. M. Van‘T Hoff, A. Van Der Ende, F. J. W. Ten Kate & Tytgat. (2001)
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole‐resistant or ‐susceptible
Helicobacter pylori
strains
. Alimentary Pharmacology & Therapeutics 13:7, pages 883-889.
Crossref
Crossref
Manuel López-Brea, Maria Josefa MartÃnez, Diego Domingo, Isabel Sánchez & Teresa Alarcón. (1999)
Metronidazole resistance and virulence factors in
Helicobacter pylori
as markers for treatment failure in a paediatric population
. FEMS Immunology & Medical Microbiology 24:2, pages 183-188.
Crossref
Crossref
Teresa Alarcón, Diego Domingo & Manuel López-Brea. (1999) Antibiotic resistance problems with Helicobacter pylori. International Journal of Antimicrobial Agents 12:1, pages 19-26.
Crossref
Crossref
PILOTTO, LEANDRO, FRANCESCHI, RASSU, BOZZOLA, FURLAN, DI MARIO & VALERIO. (1999)
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against
Helicobacter pylori
. Alimentary Pharmacology & Therapeutics 13:5, pages 667-673.
Crossref
Crossref
Peter J. Jenks, Agnes Labigne & Richard L. Ferrero. (1999)
Exposure to Metronidazole In Vivo Readily Induces Resistance in
Helicobacter pylori
and Reduces the Efficacy of Eradication Therapy in Mice
. Antimicrobial Agents and Chemotherapy 43:4, pages 777-781.
Crossref
Crossref
Nelson N S Kung, Joseph J Y Sung, Nancy W F Yuen, T H Li, P W Ng, W M Lai, Y H Lui, K N Lam, C H Choi & Edward M F Leung. (1999) One-Week Ranitidine Bismuth Citrate Versus Colloidal Bismuth Subcitrate-Based Anti- Helicobacter Triple Therapy: A Prospective Randomized Controlled Trial. American Journal of Gastroenterology 94:3, pages 721-724.
Crossref
Crossref
LIU, XIAO, SHI, WU, ZHANG, XU & TYTGAT. (1999) Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 13:3, pages 317-322.
Crossref
Crossref
XIAO, LIU, HU, XIA & TYTGAT. (1999) High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. Alimentary Pharmacology & Therapeutics 13:3, pages 311-315.
Crossref
Crossref
E. J. VAN DER WOUDEN, THIJS, A. A. VAN ZWET, KOOY & KLEIBEUKER. (1999)
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 13:3, pages 297-302.
Crossref
Crossref
Wermeille, Cunningham, Armenian, Zelger, Buri, Merki & Hadengue. (1999)
Failure of a 1-day high-dose quadruple therapy for cure of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 13:2, pages 173-177.
Crossref
Crossref
Louise Teare, Seth Saverymuttu, Robert Owen, Indrajit Tiwari & Tansy Peters. (1999) Antibiotic resistance in Helicobacter pylori. The Lancet 353:9148, pages 242.
Crossref
Crossref
M. Kist. 1999. Ökosystem Darm VIII. Ökosystem Darm VIII
185
193
.
Kent-Man Chu, Hok-Kwok Choi, Henry H Tuen, Simon Y K Law, Frank J Branicki & John Wong. (1998) A Prospective Randomized Trial Comparing the Use of Omeprazole-Based Dual and Triple Therapy for Eradication of Helicobacter pylori. American Journal of Gastroenterology 93:9, pages 1436-1442.
Crossref
Crossref
K. Wolle, M. Nilius, A. Leodolter, W. A. Müller, P. Malfertheiner & W. König. (1998) Prevalence ofHelicobacter pylori resistance to several antimicrobial agents in a region of Germany. European Journal of Clinical Microbiology & Infectious Diseases 17:7, pages 519-521.
Crossref
Crossref
Marja-Liisa Hänninen, Irmeli Happonen & Katri Jalava. (1998) Transmission of canine gastric Helicobacter salomonis infection from dam to offspring and between puppies. Veterinary Microbiology 62:1, pages 47-58.
Crossref
Crossref
M B Fennerty. (1998) SHOULD WE ABANDON METRONIDAZOLE CONTAINING HELICOBACTER PYLORI TREATMENT REGIMENS? THE CLINICAL RELEVANCE OF METRONIDAZOLE RESISTANCE. American Journal of Gastroenterology 93:1, pages 2-3.
Crossref
Crossref
W. A. De Boer. 1998. Helicobacter pylori. Helicobacter pylori
456
461
.
R. Williamson & G. A. Pipkin. 1998. Helicobacter pylori. Helicobacter pylori
416
425
.
Y. Glupczynski. 1998. Helicobacter pylori. Helicobacter pylori
398
415
.
D. I. Edwards. 1998. Helicobacter pylori. Helicobacter pylori
383
391
.
E. Rozynek, D. Dzierzanowska, D. Celińska-Cedro & J. Jeljaszewicz. (1997) Primary resistance to metronidazole and other antibiotics ofHelicobacter pylori isolated from children in Poland. European Journal of Clinical Microbiology & Infectious Diseases 16:12, pages 943-944.
Crossref
Crossref
T H HenriksenO BrorsonR SchöyenT ThoresenA Lia. (1997) A simple method for determining metronidazole resistance of Helicobacter pylori. Journal of Clinical Microbiology 35:6, pages 1424-1426.
Crossref
Crossref
Takuya Takimoto, Kiichi Satoh, Yushi Taniguchi, Koji Saifuku, Ken Kihira, Masaru Seki, Yukio Yoshida, Kenichi Ido & Ken Kimura. (2008)
The Efficacy and Safety of One‐Week Triple Therapy with Lansoprazole, Clarithromycin, and Metronidazole for the Treatment of
Helicobacter pylori
Infection in Japanese Patients
. Helicobacter 2:2, pages 86-91.
Crossref
Crossref
A. M. Segura, O. Gutierrez, W. Otero, A. Angel, R. M. Genta & D. Y. Graham. (1997) Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 11:3, pages 529-532.
Crossref
Crossref
Tove Larsen & Nils‐Erik Fiehn. (2005) Development of resistance to metronidazole and minocycline in vitro. Journal of Clinical Periodontology 24:4, pages 254-259.
Crossref
Crossref
Mahmoud M. Yousfi, Rita Reddy, Michael S. Osato & David Y. Graham. (2007) Is Antrum or Corpus the Best Site for Culture of Helicobacter pylori?. Helicobacter 1:2, pages 88-91.
Crossref
Crossref
Fiona J. Radcliff, Minhu Chen & Adrian Lee. (1996) Protective immunization against Helicobacter stimulates long-term immunity. Vaccine 14:8, pages 780-784.
Crossref
Crossref
T. H. Henriksen, Ö. Brorson, R. Schöyen & T. Thoresen. (1996) Risks related to lack of standardization of tests to detect in vitro metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 15:6, pages 484-488.
Crossref
Crossref
A VasquezY ValdezR H GilmanJ J McDonaldT U WestblomD BergH MaytaV Gutierrez. (1996) Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. The Gastrointestinal Physiology Working Group of Universidad Peruana Cayetano Heredia and the Johns Hopkins University. Journal of Clinical Microbiology 34:5, pages 1232-1234.
Crossref
Crossref
P.D. Midolo, M.G. Korman, J.D. Turnidge & J.R. Lambert. (1996) Helicobacter pylori resistance to tetracycline. The Lancet 347:9009, pages 1194-1195.
Crossref
Crossref
Thomas K.W. Ling, Augustine F.B. Cheng, Joseph J.Y. Sung, Phyllis Y.L. Yiu & Sydney S.C. Chung. (2007) An Increase in Helicobacter pylori Strains Resistant to Metronidazole: A Five‐Year Study. Helicobacter 1:1, pages 57-61.
Crossref
Crossref
René W.M. van Der Hulst, Josbert J. Keller, Erik A.J. Rauws & Guido N.J. Tytgat. (2007) Treatment of Helicobacter pylori Infection: A Review of the World Literature. Helicobacter 1:1, pages 6-19.
Crossref
Crossref
C.E. Millson, M. Wilson, A.J. MacRobert & S.G. Bown. (1996) Ex-vivo treatment of gastric Helicobacter infection by photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology 32:1-2, pages 59-65.
Crossref
Crossref
G. N. J. Tytgat. 1996. Helicobacter pylori. Helicobacter pylori
340
347
.
John H. Walsh & Walter L. Peterson. (1995)
The Treatment of
Helicobacter pylori
Infection in the Management of Peptic Ulcer Disease
. New England Journal of Medicine 333:15, pages 984-991.
Crossref
Crossref
Youri Glupczynski. (1995) Fréquence actuelle et implications cliniques de la résistance de Helicobacter pylori aux antibiotiques. Annales de l'Institut Pasteur / Actualités 6:3, pages 216-223.
Crossref
Crossref